DYNE THERAPEUTICS
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
DYNE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.dyne-tx.com
Total Employee:
11+
Status:
Active
Total Funding:
333 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Ribonexus
Ribonexus is a biotech specialized in the development of new therapies to combat cancer disease.
Capital Rx
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Cisiv
Cisiv is a developer of technology solutions for pharmaceutical companies.
Endeavor BioMedicines
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
HAYA Therapeutics
HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.
LUCA Science
LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Orasis Pharmaceuticals
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
PolyActiva
PolyActiva develops products that enable drug release from medical devices.
Priothera
Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Sydnexis
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Syndesi Therapeutics
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Logos Capital
Logos Capital investment in Series B - Dyne Therapeutics
Wellington Management
Wellington Management investment in Series B - Dyne Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Dyne Therapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - Dyne Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Dyne Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Dyne Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Dyne Therapeutics
MPM Capital
MPM Capital investment in Series B - Dyne Therapeutics
Atlas Venture
Atlas Venture investment in Series A - Dyne Therapeutics
MPM Capital
MPM Capital investment in Series A - Dyne Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-13 | Dyne Therapeutics Announces Appointment of Molly White as Vice President, Medical Communications and Advocacy |
Official Site Inspections
http://www.dyne-tx.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.53 K
- Host name: 187.128.203.35.bc.googleusercontent.com
- IP address: 35.203.128.187
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Dyne Therapeutics"
Dyne Therapeutics - LinkedIn
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the ...See details»
Dyne Therapeutics - businessabc
Feb 25, 2025 Dyne Therapeutics was founded in 2017 by Flagship Pioneering and leverage’s the team’s platform for developing transformative biologic therapies for patients with …See details»
About Us - Dyne Therapeutics
Dyne was founded with a singular focus: To transform the lives of people with serious muscle diseases by creating the first muscle-targeted therapies.See details»
About DYNE THERAPEUTICS, INC. | DxMultiomics
DYNE THERAPEUTICS, INC. | on DxMultiomics. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people …See details»
Corporate Responsibility - Dyne Therapeutics
Dyne Therapeutics is a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people living with genetically driven diseases. The FORCE™ platform drives our efforts to develop targeted …See details»
Careers + Culture - Dyne Therapeutics
Dyne is an opportunity to take cutting-edge nucleic acid-based therapeutics and use our understanding of human biology to overcome the next set of hurdles in precision medicine.See details»
Dyne Therapeutics Announces Key Leadership Appointments
Sep 3, 2024 About Dyne Therapeutics Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with …See details»
Investors & Media | Dyne Therapeutics, Inc.
Jul 2, 2025 The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Pipeline - Dyne Therapeutics
We are discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. We have a broad pipeline, including clinical programs for myotonic dystrophy type 1 (DM1) and …See details»
Cultivating A Dynamic Culture Centered Around ... - Dyne …
Apr 24, 2023 Dyne’s patient and people-centric focus brought me to the company, and I feel privileged to contribute to our culture each day. Nurturing a positive and thriving company …See details»
Committee Composition | Dyne Therapeutics, Inc.
The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Press Releases | Dyne Therapeutics, Inc.
Jun 17, 2025 The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Dyne Therapeutics (@Dyne_tx) / Twitter
Jan 2, 2019 Dr. Ashish Dugar, Chief Medical Affairs Officer at Dyne Therapeutics, presents on the ACHIEVE study and Dyne’s investigational medicine, DYNE-101. Q&A hosted by Molly …See details»
Corporate Governance | Dyne Therapeutics, Inc.
The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Dyne Therapeutics Announces CEO Transition, by @GlobeNewswire
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.See details»
Dyne Therapeutics Announces FDA Breakthrough Therapy
5 days ago Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) August 04, 2025 07:30 ET | Source: Dyne …See details»
Contact IR | Dyne Therapeutics, Inc.
The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
SEC Filings | Dyne Therapeutics, Inc. - investors.dyne-tx.com
Jun 17, 2025 The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
VP, Global Patient Advocacy - Dyne Therapeutics - dyne-tx.com
The VP, Global Patient Advocacy is the primary Dyne contact and relationship manager for PAOs and patients/families, and leads on coordination when other functions interface with these …See details»
Dyne Therapeutics Announces FDA Breakthrough Therapy …
5 days ago About Dyne Therapeutics Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are …See details»